Alphatec Holdings, Inc. (ATEC) Earnings Call Transcripts
Alphatec Holdings, Inc.'s Latest Earnings Call - May 13, 2026
In Q1 2026, Alphatec Holdings, Inc. (ATEC) reported strong financial performance, with a focus on strategic growth in the lateral surgery market and international expansion. Revenue for the quarter was not explicitly stated, but the company guided for 15% top-line growth for the year, targeting $882 million. Adjusted EBITDA guidance was set at $134 million, reflecting a 44% growth. The company also achieved positive cash flow, signaling improved financial health. Management emphasized the success of their lateral surgery offerings and the integration of new technologies like the EOS imaging system and Valence surgical robot, which are expected to drive future growth.
Reported metrics
| Metric | Value |
|---|---|
| Revenue Growth | 15% YoY (inline) |
| Adjusted EBITDA | $134 million (beat) |
| Free Cash Flow | $20 million (inline) |
| Interest Savings | $6 million annually (positive) |
Guidance from management
Management guided for 15% top-line growth, targeting $882 million in revenue, $134 million in adjusted EBITDA, and $20 million in free cash flow for FY2026. Guidance reflects confidence in continued growth and profitability expansion.
What analysts pressed on
Analysts questioned the sustainability of growth in the lateral surgery market and the potential risks associated with international expansion. Concerns were also raised about the integration and adoption of new technologies like the Valence surgical robot.
Main topics on the call
- Lateral Surgery Market Expansion — Management highlighted the lateral surgery market as a key growth area, sizing it at $1 billion and noting it as one of the fastest-growing segments. They emphasized the clinical benefits and increased adoption, stating,...
- Technological Advancements — The integration of EOS imaging and the launch of the Valence surgical robot were significant advancements. The EOS system is described as 'widely accepted as the standard' for spine care, and Valence aims to enhance surg...
- International Expansion — ATEC's international strategy focuses on 'narrow and deep' market penetration, with recent entries into Japan and successful operations in Australia and New Zealand. The first PTP procedure in Japan was completed in Marc...
- Profitability and Financial Health — The company reported a transition to positive adjusted EBITDA in 2024 and positive cash flow by the end of 2025. They refinanced $200 million of term debt, saving 300 basis points in interest, which equates to $6 million...
Read the full Alphatec Holdings, Inc. transcript (May 13, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc. (ATEC) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 47 calls on record spanning February 28, 2020 to August 4, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 47 Alphatec Holdings, Inc. earnings call transcripts on record, spanning February 28, 2020 to August 4, 2026. Based on this history, Alphatec Holdings, Inc. reports quarterly. The most recent call on file is dated August 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- ATEC
- Exchange
- NasdaqGS
- Country
- US
- Sector
- Health Care
- Calls on record
- 47
- First call
- February 28, 2020
- Most recent
- August 4, 2026
- Reporting cadence
- quarterly